INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of INDO US BIOTECH ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of INDO US BIOTECH Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹249.0 Cr | -5.7% | -4.3% | -47.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,850.9 Cr | -3.3% | -3.3% | -33% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,500.4 Cr | 9.8% | 0.9% | 16.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,906.4 Cr | 1.3% | -7.7% | -22.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,219.6 Cr | -3.6% | -6% | -26.6% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹474.6 Cr | 2.3% | -7.6% | 14.8% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -5.7% |
-4.3% |
-47.4% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses